Xtrallux, LLC

Xtrallux, LLC manufactures FDA-cleared laser therapy caps for androgenetic alopecia (male and female pattern hair loss). The company offers three primary product lines: the Xtrallux Alpha (136 diodes, entry-level), SuperPlus (276 diodes, advanced), and TurboPro (316+ diodes, professional-grade). All devices use Low-Level Laser Therapy (LLLT) at 650 nm wavelength with Surface-Mount Technology (SMT) VCSEL laser architecture. Founded by Carlos Piña, who previously introduced the first FDA-cleared home-use laser therapy cap over a decade ago, Xtrallux positions itself as the manufacturer of more powerful and higher-density laser devices than competitors. Products are indicated for mild to moderate hair loss in adults with Fitzpatrick Skin Types I–IV and are cleared for over-the-counter use. The company emphasizes clinical validation, diode density, and endorsements from hair restoration physicians including Dr. Shelly Friedman (American Board of Hair Restoration Surgery), Dr. Mark Bishara, and Dr. Tam Chu. Devices deliver 6-minute daily treatment sessions targeting unhealthy hair follicles to increase terminal hair counts. Manufacturing and direct-to-consumer sales model. No specific ISO or additional regulatory certifications mentioned beyond FDA 510(k) clearance.